1. Home
  2. ELUT vs IROH Comparison

ELUT vs IROH Comparison

Compare ELUT & IROH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELUT
  • IROH
  • Stock Information
  • Founded
  • ELUT 2015
  • IROH 2021
  • Country
  • ELUT United States
  • IROH United States
  • Employees
  • ELUT N/A
  • IROH N/A
  • Industry
  • ELUT Medical Specialities
  • IROH
  • Sector
  • ELUT Health Care
  • IROH
  • Exchange
  • ELUT Nasdaq
  • IROH Nasdaq
  • Market Cap
  • ELUT 111.2M
  • IROH 91.2M
  • IPO Year
  • ELUT 2020
  • IROH 2023
  • Fundamental
  • Price
  • ELUT $3.56
  • IROH $10.28
  • Analyst Decision
  • ELUT Strong Buy
  • IROH
  • Analyst Count
  • ELUT 2
  • IROH 0
  • Target Price
  • ELUT $10.00
  • IROH N/A
  • AVG Volume (30 Days)
  • ELUT 38.2K
  • IROH 7.4K
  • Earning Date
  • ELUT 11-14-2024
  • IROH 01-01-0001
  • Dividend Yield
  • ELUT N/A
  • IROH N/A
  • EPS Growth
  • ELUT N/A
  • IROH N/A
  • EPS
  • ELUT N/A
  • IROH 0.20
  • Revenue
  • ELUT $24,782,000.00
  • IROH N/A
  • Revenue This Year
  • ELUT $9.65
  • IROH N/A
  • Revenue Next Year
  • ELUT $39.29
  • IROH N/A
  • P/E Ratio
  • ELUT N/A
  • IROH $52.53
  • Revenue Growth
  • ELUT N/A
  • IROH N/A
  • 52 Week Low
  • ELUT $1.39
  • IROH $9.97
  • 52 Week High
  • ELUT $5.24
  • IROH $11.11
  • Technical
  • Relative Strength Index (RSI)
  • ELUT 46.89
  • IROH N/A
  • Support Level
  • ELUT $3.57
  • IROH N/A
  • Resistance Level
  • ELUT $4.02
  • IROH N/A
  • Average True Range (ATR)
  • ELUT 0.26
  • IROH 0.00
  • MACD
  • ELUT 0.04
  • IROH 0.00
  • Stochastic Oscillator
  • ELUT 48.89
  • IROH 0.00

About ELUT Elutia Inc.

Elutia Inc Formerly Aziyo Biologics Inc is a commercial-stage regenerative medicine company focused on creating the next generation of differentiated products and improving outcomes in patients undergoing surgery, concentrating on patients receiving implantable medical devices. The company's segments include Device Protection, Women's Health and Cardiovascular. It generates maximum revenue from the Women's Health segment. The products of the company are targeted to address unmet clinical needs with the goal of promoting healthy tissue formation and avoiding complications associated with medical device implants, such as scar-tissue formation, capsular contraction, erosion, migration, non-union of implants and implant rejection.

About IROH Iron Horse Acquisitions Corp. Common Stock

Iron Horse Acquisitions Corp is a blank check company.

Share on Social Networks: